Barely Significant
← all excerpts

Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.

Breast Cancer Res · 2005 · PMC1410766 · PMID 16457700

Europe PMCDOI
2
hedged sentences
0.0400
closest p · 0.8× alpha
0.0400
boldest claim

The sentences

marginally significantP = 0.04actually significant
An update presented at the 2004 American Society of Clinical Oncology meeting [ 8 ] reported a marginally significant ( P = 0.04) survival advantage for lymph node positive patients treated with letrozole.

also in 26,082 other papers

did not reach statistical significanceno p-value reported
Although these differences did not reach statistical significance, further evaluation of the impact of aromatase inhibitors on women's overall health is needed.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.